APDA Advocacy in Action: Why Medicare Payment Policy Matters

Posted on by APDA

Medicare Payment Policy Can Affect People with Parkinson’s Access to Care When most people hear the phrase “Medicare payment...see more policy,” their eyes glaze over. It sounds technical, bureaucratic, and far removed from daily life. But for people living with Parkinson’s disease (PD) and other chronic conditions, Medicare payment policy shapes whether care is available, affordable, […]

Read More

Federal Paraquat Ban Legislation Introduced

Posted on by APDA

Today, Representatives Anna Paulina Luna (R-FL) and Chellie Pingree (D-ME) introduced the Paraquat Prevention...see more Act, federal legislation aimed at banning the use of paraquat, a widely used pesticide linked in studies to an increased risk of Parkinson’s disease. The legislation represents an urgent step to protect farm workers, rural communities, […]

Read More

Presidential Budget Request Jeopardizes NIH Funding for PD Research 

Posted on by APDA

Presidential Budget Request Jeopardizes NIH Funding for Parkinson’s Research  President Trump’s FY 2027 (October 1, 2026-September 30, 2027) budget request, released on April...see more 3, includes a 20% cut to the National Institutes of Health (NIH). The proposed cuts jeopardize efforts to increase NIH funding for Parkinson’s disease (PD) research. The American Parkinson Disease Association (APDA), in unison with the Michael J. Fox Foundation and the Parkinson’s Foundation, […]

Read More

Bipartisan HEALTHY BRAINS Act Introduced to Combat Rising Neurodegenerative Disease Crisis

Posted on by APDA

APDA’s Public Policy & Advocacy team was on hand yesterday as lawmakers unveiled the Harmonizing Environmental Analyses and Launching...see more Therapeutic Hubs to Yield Bolstered Research and Innovation in Neurological Science (HEALTHY BRAINS) Act (H.R. 7779.) Introduced by Representative Gus Bilirakis (R-FL) and Representative Suhas Subramanyam (D-VA), the sweeping bipartisan initiative is aimed at strengthening federal […]

Read More

Syngenta to Cease Paraquat Production, Fight for Full Ban Must Continue 

Posted on by APDA

Syngenta to Cease Paraquat Production, Fight for Full Ban Must Continue  In a significant development for the agricultural and public health...see more communities, Syngenta announced that in June 2026 it will stop producing paraquat, a widely used and highly toxic herbicide that has been linked in multiple scientific studies to an increased risk of Parkinson’s disease (PD).  Anne Hubbard, APDA’s Chief Public […]

Read More

Paraquat & Parkinson’s Disease: A Public Health Crisis — and Why We Must Act Now

Posted on by Anne Hubbard

Paraquat is banned in 70+ countries, but still legal in the US For the Parkinson’s community, this isn’t abstract...see more science, it’s personal reality. Studies have shown that people exposed to paraquat are more likely to develop Parkinson’s disease (PD) than those who are not exposed. And thousands of families across the U.S. have now pursued […]

Read More

Parkinson’s Advocacy: A Conversation with Anne Hubbard, APDA’s Chief Public Policy Officer

Posted on by Rebecca Gilbert, MD, Ph.D.

In August 2025, the American Parkinson Disease Association (APDA) welcomed Anne Hubbard as its first-ever Chief Public Policy Officer,...see more marking a major step forward in strengthening the organization’s voice in public policy and advocacy. Anne now leads APDA’s newly created Department of Public Policy & Advocacy, where she is developing a comprehensive strategy to promote […]

Read More

Parkinson’s Disease Advocacy at APDA

Posted on by Anne Hubbard

We’re at a Turning Point for Parkinson’s — Your Story Can Help Move Congress The Parkinson’s disease (PD) community...see more is currently facing both urgent challenges and real opportunities. More than 90,000 Americans are diagnosed each year, and over 1 million people are living with Parkinson’s nationwide. At the same time, new legislation, scientific progress, and […]

Read More